<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03379740</url>
  </required_header>
  <id_info>
    <org_study_id>P4M3-PK-02-US</org_study_id>
    <nct_id>NCT03379740</nct_id>
  </id_info>
  <brief_title>Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants</brief_title>
  <official_title>A Single-center, Open-label, Concentration-ranging Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of the P4M3 Variants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philip Morris Products S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philip Morris Products S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, open-label, concentration-ranging study to evaluate the nicotine PK
      profile and PD effects in healthy adult experienced users of closed tank/cartridge
      e-cigarettes using four different variants of P4M3 (nicotine concentration of 1.7%, 1.7% with
      1.1% lactic acid [LA], 3% with 1.1% LA, and 4% with 2% LA) or their own e-cigarettes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the study is to evaluate the nicotine concentration profiles and derived PK
      parameters, subjective effects, behavioral parameters, including puffing topography
      parameters of P4M3 with four different variants of P4M3, in experienced e-cigarette users
      after a single-use experience with fixed puffing regime and after ad libitum use of P4M3.

      Four variants of P4M3 will be evaluated together with subjects' own e-cigarettes to evaluate
      the relationship between the e-liquid composition (nicotine concentrations and presence of
      lactic acid) and the amount of nicotine absorbed, the speed of absorption, and the puffing
      topography.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 11, 2017</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">August 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This is an open-label study; however the site (except the pharmacy staff preparing the IPs for administration) will be masked to the randomization sequences until they are assigned. Subjects will not be informed of the complete sequence to which they have been assigned to receive the P4M3 products.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Nicotine Concentration Versus Time Profile</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure total and background-corrected plasma nicotine concentration versus time profiles from 60 minutes of ad libitum use.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Plasma Nicotine Concentration [cCpeak]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure background-corrected peak plasma nicotine concentration [cCpeak] from 60 minutes of ad libitum use.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Peak Plasma Nicotine Concentration [Tpeak]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure the time to peak plasma nicotine concentration [tpeak] from 60 minutes of ad libitum use.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Background-corrected Trough Plasma Nicotine Concentration [cCtrough]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure background-corrected trough plasma nicotine concentration [cCtrough] from 60 minutes of ad libitum use.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Background-corrected Average of Plasma Nicotine Concentration [cCaverage]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure background-corrected average of plasma nicotine concentration between 0 to 1 hour [cCaverage] from 60 minutes of ad libitum use.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total and Background-corrected Plasma Nicotine Concentration Versus Time Profiles</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure the total and background-corrected plasma nicotine concentration versus time profiles of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background-corrected Maximum Plasma Concentration [cCmax]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure the background-corrected maximum plasma concentration [cCmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the Maximum Concentration [Tmax]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure the time to the maximum concentration [tmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Background-corrected Area Under the Concentration-time Curve [cAUC(0-4h)]</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>To measure the background-corrected area under the concentration-time curve, which is above the corrected baseline from the start of product use to 4 hours [cAUC(0-4h)], of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Effects of P4M3 Use</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>Measured with an adapted version of the modified Cigarette Evaluation Questionnaire (adapted mCEQ) within 60 minutes after the ad libitum use session. Assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Curve of Craving for an Electronic Cigarette</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>Measured on a Visual Analogue Scale (VAS) of 0 (no craving) to 100 (strong craving), before and after the fixed puffing regimen and ad libitum use period. (The VAS craving was measured from 0 to 100 on a 100 mm scale.)
The data below present the Area under the VAS craving score-time curve from the start of product use to 4 hours.
The area under the curve for VAS craving is an integrated measurement of the VAS craving taking into account several timepoints. AUC was calculated using a trapezoidal rule between timepoints without normalization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory Parameters (Fixed Puffing Regimen)</measure>
    <time_frame>From Day 1 to Day 4</time_frame>
    <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each fixed puffing regimen use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory Parameters (ad Libitum Use)</measure>
    <time_frame>From Day 1 to Day 4</time_frame>
    <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each ad libitum use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Human Puffing Topography (HPT) of the P4M3 Variants and the Subjects' Own E-cigarette</measure>
    <time_frame>From Day -1 (baseline) to Day 4</time_frame>
    <description>Total Puff Volume measured for the P4M3 variants and the subjects' own e-cigarette from the fixed puffing regimen and the 60 minutes ad libitum use.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Vaping</condition>
  <condition>Nicotine Absorption</condition>
  <arm_group>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
Subject's own e-cigarette; P4M3-1.7%; P4M3-1.7%LA; P4M3-3%LA; and P4M3-4%LA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
Subject's own e-cigarette; P4M3-1.7%LA; P4M3-1.7%; P4M3-3%LA; and P4M3-4%LA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-cigarette</intervention_name>
    <description>Subject's own e-cigarette</description>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P4M3-1.7%</intervention_name>
    <description>P4M3 e-liquid concentration of 1.7% nicotine without lactic acid</description>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P4M3-1.7%LA</intervention_name>
    <description>P4M3 e-liquid concentration of 1.7% nicotine with lactic acid</description>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P4M3-3%LA</intervention_name>
    <description>P4M3 e-liquid concentration of 3% nicotine with lactic acid</description>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P4M3-4%LA</intervention_name>
    <description>P4M3 e-liquid concentration of 4% nicotine with lactic acid</description>
    <arm_group_label>Product Exposure Sequence 1</arm_group_label>
    <arm_group_label>Product Exposure Sequence 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has signed the informed consent form (ICF) and is able to understand the
             information provided in the ICF.

          -  Subject is 21 to 65 years of age, inclusive, at the Screening Visit.

          -  Subject is a former daily cigarette smoker who smoked at least 100 cigarettes or more
             in his/her life and ceased smoking at least 3 months prior to the Screening Visit.

          -  Subject has been using a commercially available, nicotine-containing closed
             tank/cartridge e-cigarette daily for at least 3 months prior to the Screening Visit.

          -  Subject has a urine cotinine test ≥200 ng/mL at the Screening Visit and Admission.

        Exclusion Criteria:

          -  Subject has a clinically relevant disease which requires medication which as per the
             judgment of the Investigator would jeopardize the safety of the subject.

          -  Subject has abnormal renal function test result or subject with a creatinine clearance
             &lt;60 mL/minute at the Screening Visit, confirmed on repeat testing.

          -  Subject has elevated liver function test results at the Screening Visit.

          -  Subject has bilirubin &gt;1.5X ULN at the Screening Visit.

          -  Subject has FEV1/FVC &lt;0.7 and FEV1 &lt;80% predicted value at post-bronchodilator
             spirometry at the Screening Visit.

          -  Subject has asthma condition at the Screening Visit.

          -  Subject has received medication within 14 days or within 5 half-lives of the drug
             (whichever is longer) prior to Admission, which has an impact on cytochrome P450 (CYP)
             2A6 activity.

          -  Subject has a carbon monoxide (CO) breath test ≥ 10 ppm at the Screening Visit or
             Admission.

          -  Subject has a body mass index (BMI) &lt;18.5 kg/m2 or BMI ≥35 kg/m2 at the Screening
             Visit.

          -  Subject has a positive serology test for human immunodeficiency virus (HIV) 1/2,
             hepatitis B, or hepatitis C at the Screening Visit.

          -  Subject has clinically significant ECG findings at the Screening Visit.

          -  Subject has participated in a clinical study within 3 months prior to the Screening
             Visit.

          -  Subject smokes cigarettes or uses other tobacco products.

          -  Female subject of childbearing potential who is pregnant or breastfeeding.

          -  Female subject of childbearing potential who does not agree to use an acceptable
             method of effective contraception..
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christelle Haziza, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Philip Morris Products S.A.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonathan Austin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>High Point Clinical Trials Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>High Point Clinical Trials Center</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27265</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 1, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <results_first_submitted>September 3, 2019</results_first_submitted>
  <results_first_submitted_qc>November 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 22, 2019</results_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nicotine-containing product</keyword>
  <keyword>Alternative to cigarettes</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 10, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/40/NCT03379740/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 10, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/40/NCT03379740/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Product Exposure Sequence 1</title>
          <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
E-cigarette; P4M3-1.7%; P4M3-1.7%LA; P4M3-3%LA; and P4M3-4%LA
E-cigarette: Subject's own e-cigarette
P4M3-1.7%: P4M3 e-liquid concentration of 1.7% nicotine without lactic acid
P4M3-1.7%LA: P4M3 e-liquid concentration of 1.7% nicotine with lactic acid
P4M3-3%LA: P4M3 e-liquid concentration of 3% nicotine with lactic acid
P4M3-4%LA: P4M3 e-liquid concentration of 4% nicotine with lactic acid</description>
        </group>
        <group group_id="P2">
          <title>Product Exposure Sequence 2</title>
          <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
E-cigarette; P4M3-1.7%LA; P4M3-1.7%; P4M3-3%LA; and P4M3-4%LA
E-cigarette: Subject's own e-cigarette
P4M3-1.7%: P4M3 e-liquid concentration of 1.7% nicotine without lactic acid
P4M3-1.7%LA: P4M3 e-liquid concentration of 1.7% nicotine with lactic acid
P4M3-3%LA: P4M3 e-liquid concentration of 3% nicotine with lactic acid
P4M3-4%LA: P4M3 e-liquid concentration of 4% nicotine with lactic acid</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Product Exposure Sequence 1</title>
          <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
E-cigarette; P4M3-1.7%; P4M3-1.7%LA; P4M3-3%LA; and P4M3-4%LA
E-cigarette: Subject's own e-cigarette
P4M3-1.7%: P4M3 e-liquid concentration of 1.7% nicotine without lactic acid
P4M3-1.7%LA: P4M3 e-liquid concentration of 1.7% nicotine with lactic acid
P4M3-3%LA: P4M3 e-liquid concentration of 3% nicotine with lactic acid
P4M3-4%LA: P4M3 e-liquid concentration of 4% nicotine with lactic acid</description>
        </group>
        <group group_id="B2">
          <title>Product Exposure Sequence 2</title>
          <description>Subjects will be randomized to follow a sequence of product exposure comprised of :
E-cigarette; P4M3-1.7%LA; P4M3-1.7%; P4M3-3%LA; and P4M3-4%LA
E-cigarette: Subject's own e-cigarette
P4M3-1.7%: P4M3 e-liquid concentration of 1.7% nicotine without lactic acid
P4M3-1.7%LA: P4M3 e-liquid concentration of 1.7% nicotine with lactic acid
P4M3-3%LA: P4M3 e-liquid concentration of 3% nicotine with lactic acid
P4M3-4%LA: P4M3 e-liquid concentration of 4% nicotine with lactic acid</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.3" lower_limit="22" upper_limit="59"/>
                    <measurement group_id="B2" value="42.0" lower_limit="21" upper_limit="55"/>
                    <measurement group_id="B3" value="40.0" lower_limit="21" upper_limit="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.95" lower_limit="65.1" upper_limit="120.5"/>
                    <measurement group_id="B2" value="70.41" lower_limit="61.6" upper_limit="89.1"/>
                    <measurement group_id="B3" value="77.63" lower_limit="61.6" upper_limit="120.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (cm)</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178.2" lower_limit="171" upper_limit="186"/>
                    <measurement group_id="B2" value="165.0" lower_limit="149" upper_limit="180"/>
                    <measurement group_id="B3" value="172.1" lower_limit="149" upper_limit="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (kg/m^2)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.361" lower_limit="19.40" upper_limit="34.94"/>
                    <measurement group_id="B2" value="26.174" lower_limit="21.22" upper_limit="34.80"/>
                    <measurement group_id="B3" value="26.274" lower_limit="19.40" upper_limit="34.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Nicotine Concentration Versus Time Profile</title>
        <description>To measure total and background-corrected plasma nicotine concentration versus time profiles from 60 minutes of ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Nicotine Concentration Versus Time Profile</title>
          <description>To measure total and background-corrected plasma nicotine concentration versus time profiles from 60 minutes of ad libitum use.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.546" spread="99.52"/>
                    <measurement group_id="O2" value="3.165" spread="77.27"/>
                    <measurement group_id="O3" value="4.167" spread="119.38"/>
                    <measurement group_id="O4" value="7.518" spread="93.39"/>
                    <measurement group_id="O5" value="6.782" spread="95.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.235" spread="103.89"/>
                    <measurement group_id="O2" value="5.237" spread="65.20"/>
                    <measurement group_id="O3" value="6.990" spread="121.67"/>
                    <measurement group_id="O4" value="11.92" spread="65.52"/>
                    <measurement group_id="O5" value="9.942" spread="65.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.852" spread="113.80"/>
                    <measurement group_id="O2" value="7.808" spread="62.57"/>
                    <measurement group_id="O3" value="8.165" spread="111.02"/>
                    <measurement group_id="O4" value="17.85" spread="66.05"/>
                    <measurement group_id="O5" value="14.65" spread="60.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.25" spread="111.09"/>
                    <measurement group_id="O2" value="9.338" spread="61.00"/>
                    <measurement group_id="O3" value="9.852" spread="99.60"/>
                    <measurement group_id="O4" value="20.72" spread="63.01"/>
                    <measurement group_id="O5" value="19.17" spread="56.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.46" spread="80.78"/>
                    <measurement group_id="O2" value="13.24" spread="55.46"/>
                    <measurement group_id="O3" value="12.64" spread="96.63"/>
                    <measurement group_id="O4" value="25.53" spread="62.65"/>
                    <measurement group_id="O5" value="25.77" spread="55.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.809" spread="90.18"/>
                    <measurement group_id="O2" value="9.356" spread="69.35"/>
                    <measurement group_id="O3" value="7.157" spread="102.04"/>
                    <measurement group_id="O4" value="15.52" spread="52.34"/>
                    <measurement group_id="O5" value="12.76" spread="50.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>240 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.297" spread="91.97"/>
                    <measurement group_id="O2" value="4.524" spread="76.68"/>
                    <measurement group_id="O3" value="3.311" spread="91.70"/>
                    <measurement group_id="O4" value="7.490" spread="53.81"/>
                    <measurement group_id="O5" value="5.681" spread="45.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Peak Plasma Nicotine Concentration [cCpeak]</title>
        <description>To measure background-corrected peak plasma nicotine concentration [cCpeak] from 60 minutes of ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Plasma Nicotine Concentration [cCpeak]</title>
          <description>To measure background-corrected peak plasma nicotine concentration [cCpeak] from 60 minutes of ad libitum use.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.87" spread="83.01"/>
                    <measurement group_id="O2" value="13.32" spread="55.65"/>
                    <measurement group_id="O3" value="13.05" spread="98.16"/>
                    <measurement group_id="O4" value="26.47" spread="63.68"/>
                    <measurement group_id="O5" value="26.57" spread="57.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Peak Plasma Nicotine Concentration [Tpeak]</title>
        <description>To measure the time to peak plasma nicotine concentration [tpeak] from 60 minutes of ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Peak Plasma Nicotine Concentration [Tpeak]</title>
          <description>To measure the time to peak plasma nicotine concentration [tpeak] from 60 minutes of ad libitum use.</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.000" lower_limit="30.00" upper_limit="65.00"/>
                    <measurement group_id="O2" value="60.000" lower_limit="60.00" upper_limit="122.00"/>
                    <measurement group_id="O3" value="60.000" lower_limit="40.00" upper_limit="60.00"/>
                    <measurement group_id="O4" value="60.000" lower_limit="30.00" upper_limit="60.00"/>
                    <measurement group_id="O5" value="60.000" lower_limit="40.00" upper_limit="65.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Background-corrected Trough Plasma Nicotine Concentration [cCtrough]</title>
        <description>To measure background-corrected trough plasma nicotine concentration [cCtrough] from 60 minutes of ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Background-corrected Trough Plasma Nicotine Concentration [cCtrough]</title>
          <description>To measure background-corrected trough plasma nicotine concentration [cCtrough] from 60 minutes of ad libitum use.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.492" spread="98.26"/>
                    <measurement group_id="O2" value="2.819" spread="74.17"/>
                    <measurement group_id="O3" value="2.905" spread="101.32"/>
                    <measurement group_id="O4" value="6.032" spread="73.40"/>
                    <measurement group_id="O5" value="4.845" spread="59.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Background-corrected Average of Plasma Nicotine Concentration [cCaverage]</title>
        <description>To measure background-corrected average of plasma nicotine concentration between 0 to 1 hour [cCaverage] from 60 minutes of ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Background-corrected Average of Plasma Nicotine Concentration [cCaverage]</title>
          <description>To measure background-corrected average of plasma nicotine concentration between 0 to 1 hour [cCaverage] from 60 minutes of ad libitum use.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.548" spread="95.38"/>
                    <measurement group_id="O2" value="7.302" spread="55.95"/>
                    <measurement group_id="O3" value="7.870" spread="101.89"/>
                    <measurement group_id="O4" value="16.03" spread="62.01"/>
                    <measurement group_id="O5" value="14.48" spread="55.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total and Background-corrected Plasma Nicotine Concentration Versus Time Profiles</title>
        <description>To measure the total and background-corrected plasma nicotine concentration versus time profiles of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Total and Background-corrected Plasma Nicotine Concentration Versus Time Profiles</title>
          <description>To measure the total and background-corrected plasma nicotine concentration versus time profiles of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>2 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.228" spread="138.63"/>
                    <measurement group_id="O2" value="0.7868" spread="268.65"/>
                    <measurement group_id="O3" value="1.620" spread="117.19"/>
                    <measurement group_id="O4" value="2.025" spread="165.36"/>
                    <measurement group_id="O5" value="3.634" spread="143.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.158" spread="107.95"/>
                    <measurement group_id="O2" value="1.915" spread="120.88"/>
                    <measurement group_id="O3" value="4.048" spread="126.28"/>
                    <measurement group_id="O4" value="4.817" spread="113.35"/>
                    <measurement group_id="O5" value="7.356" spread="65.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.960" spread="81.41"/>
                    <measurement group_id="O2" value="3.992" spread="77.63"/>
                    <measurement group_id="O3" value="5.869" spread="83.79"/>
                    <measurement group_id="O4" value="8.162" spread="67.20"/>
                    <measurement group_id="O5" value="9.905" spread="69.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.443" spread="80.92"/>
                    <measurement group_id="O2" value="4.386" spread="66.40"/>
                    <measurement group_id="O3" value="5.232" spread="72.58"/>
                    <measurement group_id="O4" value="7.793" spread="57.17"/>
                    <measurement group_id="O5" value="9.480" spread="68.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.810" spread="71.38"/>
                    <measurement group_id="O2" value="3.788" spread="60.59"/>
                    <measurement group_id="O3" value="4.250" spread="74.72"/>
                    <measurement group_id="O4" value="7.251" spread="57.53"/>
                    <measurement group_id="O5" value="8.152" spread="57.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.209" spread="83.26"/>
                    <measurement group_id="O2" value="2.704" spread="98.56"/>
                    <measurement group_id="O3" value="3.202" spread="73.14"/>
                    <measurement group_id="O4" value="5.232" spread="57.79"/>
                    <measurement group_id="O5" value="6.203" spread="66.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.365" spread="93.30"/>
                    <measurement group_id="O2" value="2.300" spread="52.26"/>
                    <measurement group_id="O3" value="2.352" spread="71.13"/>
                    <measurement group_id="O4" value="3.646" spread="62.22"/>
                    <measurement group_id="O5" value="4.238" spread="74.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>120 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.579" spread="96.29"/>
                    <measurement group_id="O2" value="1.292" spread="52.31"/>
                    <measurement group_id="O3" value="1.479" spread="68.44"/>
                    <measurement group_id="O4" value="2.074" spread="65.23"/>
                    <measurement group_id="O5" value="2.398" spread="79.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>240 mins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8435" spread="81.99"/>
                    <measurement group_id="O2" value="0.6550" spread="50.33"/>
                    <measurement group_id="O3" value="0.6794" spread="84.09"/>
                    <measurement group_id="O4" value="1.038" spread="54.59"/>
                    <measurement group_id="O5" value="1.183" spread="74.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Background-corrected Maximum Plasma Concentration [cCmax]</title>
        <description>To measure the background-corrected maximum plasma concentration [cCmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Background-corrected Maximum Plasma Concentration [cCmax]</title>
          <description>To measure the background-corrected maximum plasma concentration [cCmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.402" spread="78.06"/>
                    <measurement group_id="O2" value="5.074" spread="77.64"/>
                    <measurement group_id="O3" value="6.735" spread="83.39"/>
                    <measurement group_id="O4" value="9.437" spread="63.11"/>
                    <measurement group_id="O5" value="11.990" spread="78.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to the Maximum Concentration [Tmax]</title>
        <description>To measure the time to the maximum concentration [tmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the Maximum Concentration [Tmax]</title>
          <description>To measure the time to the maximum concentration [tmax] of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.002" lower_limit="4.00" upper_limit="120.00"/>
                    <measurement group_id="O2" value="10.002" lower_limit="4.00" upper_limit="60.00"/>
                    <measurement group_id="O3" value="7.002" lower_limit="4.00" upper_limit="30.00"/>
                    <measurement group_id="O4" value="10.002" lower_limit="4.00" upper_limit="15.00"/>
                    <measurement group_id="O5" value="7.002" lower_limit="2.00" upper_limit="15.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Background-corrected Area Under the Concentration-time Curve [cAUC(0-4h)]</title>
        <description>To measure the background-corrected area under the concentration-time curve, which is above the corrected baseline from the start of product use to 4 hours [cAUC(0-4h)], of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <population>Values below the Lower Limit of Quantification were set to missing.</population>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Background-corrected Area Under the Concentration-time Curve [cAUC(0-4h)]</title>
          <description>To measure the background-corrected area under the concentration-time curve, which is above the corrected baseline from the start of product use to 4 hours [cAUC(0-4h)], of the P4M3 variants and subjects' own e-cigarette from the fixed puffing regimen.</description>
          <population>Values below the Lower Limit of Quantification were set to missing.</population>
          <units>ng*h/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fixed Regimen</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.796" spread="81.19"/>
                    <measurement group_id="O2" value="6.969" spread="50.19"/>
                    <measurement group_id="O3" value="7.679" spread="66.36"/>
                    <measurement group_id="O4" value="11.55" spread="56.00"/>
                    <measurement group_id="O5" value="13.570" spread="67.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ad libitum</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.77" spread="86.94"/>
                    <measurement group_id="O2" value="33.03" spread="61.44"/>
                    <measurement group_id="O3" value="28.64" spread="96.87"/>
                    <measurement group_id="O4" value="60.21" spread="55.29"/>
                    <measurement group_id="O5" value="52.79" spread="50.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Effects of P4M3 Use</title>
        <description>Measured with an adapted version of the modified Cigarette Evaluation Questionnaire (adapted mCEQ) within 60 minutes after the ad libitum use session. Assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects of P4M3 Use</title>
          <description>Measured with an adapted version of the modified Cigarette Evaluation Questionnaire (adapted mCEQ) within 60 minutes after the ad libitum use session. Assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Product Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.76" spread="1.058"/>
                    <measurement group_id="O2" value="3.62" spread="1.425"/>
                    <measurement group_id="O3" value="3.49" spread="1.667"/>
                    <measurement group_id="O4" value="3.24" spread="1.165"/>
                    <measurement group_id="O5" value="3.04" spread="1.469"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological Reward</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.88" spread="1.242"/>
                    <measurement group_id="O2" value="3.49" spread="1.396"/>
                    <measurement group_id="O3" value="3.13" spread="1.529"/>
                    <measurement group_id="O4" value="3.01" spread="1.060"/>
                    <measurement group_id="O5" value="2.88" spread="1.207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aversion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.77" spread="0.864"/>
                    <measurement group_id="O2" value="1.57" spread="0.843"/>
                    <measurement group_id="O3" value="2.00" spread="1.036"/>
                    <measurement group_id="O4" value="2.37" spread="1.518"/>
                    <measurement group_id="O5" value="2.53" spread="1.788"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Enjoyment of Respiratory Tract Sensations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="1.23"/>
                    <measurement group_id="O2" value="3.2" spread="1.02"/>
                    <measurement group_id="O3" value="3.1" spread="1.23"/>
                    <measurement group_id="O4" value="3.0" spread="0.93"/>
                    <measurement group_id="O5" value="2.9" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Craving Reduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="1.67"/>
                    <measurement group_id="O2" value="3.9" spread="1.25"/>
                    <measurement group_id="O3" value="3.7" spread="1.80"/>
                    <measurement group_id="O4" value="3.6" spread="1.51"/>
                    <measurement group_id="O5" value="3.5" spread="1.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Curve of Craving for an Electronic Cigarette</title>
        <description>Measured on a Visual Analogue Scale (VAS) of 0 (no craving) to 100 (strong craving), before and after the fixed puffing regimen and ad libitum use period. (The VAS craving was measured from 0 to 100 on a 100 mm scale.)
The data below present the Area under the VAS craving score-time curve from the start of product use to 4 hours.
The area under the curve for VAS craving is an integrated measurement of the VAS craving taking into account several timepoints. AUC was calculated using a trapezoidal rule between timepoints without normalization.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve of Craving for an Electronic Cigarette</title>
          <description>Measured on a Visual Analogue Scale (VAS) of 0 (no craving) to 100 (strong craving), before and after the fixed puffing regimen and ad libitum use period. (The VAS craving was measured from 0 to 100 on a 100 mm scale.)
The data below present the Area under the VAS craving score-time curve from the start of product use to 4 hours.
The area under the curve for VAS craving is an integrated measurement of the VAS craving taking into account several timepoints. AUC was calculated using a trapezoidal rule between timepoints without normalization.</description>
          <units>score*hr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fixed Puffing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="154.8" spread="120.90"/>
                    <measurement group_id="O2" value="134.4" spread="117.02"/>
                    <measurement group_id="O3" value="135.5" spread="120.61"/>
                    <measurement group_id="O4" value="141.8" spread="105.87"/>
                    <measurement group_id="O5" value="124.9" spread="106.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ad Libitum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="143.2" spread="87.05"/>
                    <measurement group_id="O2" value="117.9" spread="84.65"/>
                    <measurement group_id="O3" value="119.5" spread="100.03"/>
                    <measurement group_id="O4" value="108.0" spread="89.93"/>
                    <measurement group_id="O5" value="96.9" spread="90.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensory Parameters (Fixed Puffing Regimen)</title>
        <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each fixed puffing regimen use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
        <time_frame>From Day 1 to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Sensory Parameters (Fixed Puffing Regimen)</title>
          <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each fixed puffing regimen use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>How much did you like the puffs you took?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="1.41"/>
                    <measurement group_id="O2" value="3.7" spread="1.34"/>
                    <measurement group_id="O3" value="3.7" spread="1.86"/>
                    <measurement group_id="O4" value="3.5" spread="1.73"/>
                    <measurement group_id="O5" value="3.5" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>How harsh were the puffs you took?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="1.41"/>
                    <measurement group_id="O2" value="4.4" spread="1.30"/>
                    <measurement group_id="O3" value="3.2" spread="1.53"/>
                    <measurement group_id="O4" value="4.1" spread="1.19"/>
                    <measurement group_id="O5" value="3.7" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>How similar to your own brand were the puffs?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="1.81"/>
                    <measurement group_id="O2" value="2.3" spread="1.18"/>
                    <measurement group_id="O3" value="2.3" spread="1.64"/>
                    <measurement group_id="O4" value="2.1" spread="1.07"/>
                    <measurement group_id="O5" value="2.3" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs on tongue?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="1.13"/>
                    <measurement group_id="O2" value="2.8" spread="1.09"/>
                    <measurement group_id="O3" value="2.5" spread="1.10"/>
                    <measurement group_id="O4" value="2.8" spread="1.21"/>
                    <measurement group_id="O5" value="3.0" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in nose?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.92"/>
                    <measurement group_id="O2" value="2.2" spread="1.02"/>
                    <measurement group_id="O3" value="1.8" spread="0.81"/>
                    <measurement group_id="O4" value="2.2" spread="0.87"/>
                    <measurement group_id="O5" value="2.3" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in back of mouth &amp; throat?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="1.30"/>
                    <measurement group_id="O2" value="4.1" spread="1.19"/>
                    <measurement group_id="O3" value="2.9" spread="1.10"/>
                    <measurement group_id="O4" value="3.9" spread="1.34"/>
                    <measurement group_id="O5" value="3.9" spread="1.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in windpipe?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.44"/>
                    <measurement group_id="O2" value="4.1" spread="1.10"/>
                    <measurement group_id="O3" value="3.1" spread="1.08"/>
                    <measurement group_id="O4" value="4.1" spread="1.49"/>
                    <measurement group_id="O5" value="3.8" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength puffs in chest?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="1.13"/>
                    <measurement group_id="O2" value="3.5" spread="1.41"/>
                    <measurement group_id="O3" value="2.2" spread="1.13"/>
                    <measurement group_id="O4" value="3.5" spread="1.83"/>
                    <measurement group_id="O5" value="3.2" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensory Parameters (ad Libitum Use)</title>
        <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each ad libitum use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
        <time_frame>From Day 1 to Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Sensory Parameters (ad Libitum Use)</title>
          <description>Measured with a Sensory Questionnaire (SQ) within 60 minutes after each ad libitum use period. Response to each question is assessed on a 7-point scale, ranging from 1 (not at all) to 7 (extremely).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>How much did you like the puffs you took?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="1.23"/>
                    <measurement group_id="O2" value="3.9" spread="1.69"/>
                    <measurement group_id="O3" value="3.4" spread="1.64"/>
                    <measurement group_id="O4" value="3.6" spread="1.30"/>
                    <measurement group_id="O5" value="3.1" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>How harsh were the puffs you took?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.28"/>
                    <measurement group_id="O2" value="3.9" spread="1.44"/>
                    <measurement group_id="O3" value="3.3" spread="1.45"/>
                    <measurement group_id="O4" value="3.3" spread="1.80"/>
                    <measurement group_id="O5" value="3.9" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>How similar to your own brand were the puffs?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="2.05"/>
                    <measurement group_id="O2" value="2.2" spread="1.09"/>
                    <measurement group_id="O3" value="2.1" spread="1.34"/>
                    <measurement group_id="O4" value="2.1" spread="1.04"/>
                    <measurement group_id="O5" value="2.1" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs on tongue?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.20"/>
                    <measurement group_id="O2" value="2.7" spread="1.05"/>
                    <measurement group_id="O3" value="2.5" spread="1.07"/>
                    <measurement group_id="O4" value="2.8" spread="1.15"/>
                    <measurement group_id="O5" value="2.5" spread="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in nose?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.04"/>
                    <measurement group_id="O2" value="2.0" spread="0.93"/>
                    <measurement group_id="O3" value="2.0" spread="1.07"/>
                    <measurement group_id="O4" value="2.1" spread="0.89"/>
                    <measurement group_id="O5" value="1.8" spread="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in back of mouth &amp; throat?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.92"/>
                    <measurement group_id="O2" value="3.5" spread="1.46"/>
                    <measurement group_id="O3" value="2.7" spread="1.17"/>
                    <measurement group_id="O4" value="3.4" spread="1.25"/>
                    <measurement group_id="O5" value="3.7" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength of puffs in windpipe?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="1.00"/>
                    <measurement group_id="O2" value="3.9" spread="1.63"/>
                    <measurement group_id="O3" value="2.9" spread="0.89"/>
                    <measurement group_id="O4" value="3.5" spread="1.31"/>
                    <measurement group_id="O5" value="3.7" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strength puffs in chest?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.04"/>
                    <measurement group_id="O2" value="3.3" spread="1.55"/>
                    <measurement group_id="O3" value="2.9" spread="1.07"/>
                    <measurement group_id="O4" value="3.3" spread="1.45"/>
                    <measurement group_id="O5" value="3.2" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Human Puffing Topography (HPT) of the P4M3 Variants and the Subjects' Own E-cigarette</title>
        <description>Total Puff Volume measured for the P4M3 variants and the subjects' own e-cigarette from the fixed puffing regimen and the 60 minutes ad libitum use.</description>
        <time_frame>From Day -1 (baseline) to Day 4</time_frame>
        <population>HPT raw data were reviewed for recording errors by personnel independent from the study and accepted or rejected prior to analysis. HPT data with the ‘Rejected’ status were excluded from the analysis. Consequently, the number of subjects analyzed differ from the overall number of subjects analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Subject's Own E-cigarette</title>
            <description>Subject's own e-cigarette with e-liquid</description>
          </group>
          <group group_id="O2">
            <title>P4M3-1.7%</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
          </group>
          <group group_id="O3">
            <title>P4M3-1.7%LA</title>
            <description>P4M3 with e-liquid concentrations of 1.7% nicotine with lactic acid</description>
          </group>
          <group group_id="O4">
            <title>P4M3-3%LA</title>
            <description>P4M3 with e-liquid concentrations of 3% nicotine with lactic acid</description>
          </group>
          <group group_id="O5">
            <title>P4M3-4%LA</title>
            <description>P4M3 with e-liquid concentrations of 4% nicotine with lactic acid</description>
          </group>
        </group_list>
        <measure>
          <title>Human Puffing Topography (HPT) of the P4M3 Variants and the Subjects' Own E-cigarette</title>
          <description>Total Puff Volume measured for the P4M3 variants and the subjects' own e-cigarette from the fixed puffing regimen and the 60 minutes ad libitum use.</description>
          <population>HPT raw data were reviewed for recording errors by personnel independent from the study and accepted or rejected prior to analysis. HPT data with the ‘Rejected’ status were excluded from the analysis. Consequently, the number of subjects analyzed differ from the overall number of subjects analyzed.</population>
          <units>mL (Total Puff Volume)</units>
          <param>Geometric Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fixed Puffing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1103.2913" lower_limit="896.5624" upper_limit="1682.3241"/>
                    <measurement group_id="O2" value="1133.2255" lower_limit="878.6965" upper_limit="1844.3455"/>
                    <measurement group_id="O3" value="1235.2367" lower_limit="874.7012" upper_limit="2069.0103"/>
                    <measurement group_id="O4" value="1139.8381" lower_limit="857.5359" upper_limit="1877.5095"/>
                    <measurement group_id="O5" value="935.8970" lower_limit="739.5238" upper_limit="1408.0820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ad Libitum</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2054.8081" lower_limit="1699.3244" upper_limit="2881.0980"/>
                    <measurement group_id="O2" value="2752.3456" lower_limit="2232.0269" upper_limit="3976.0701"/>
                    <measurement group_id="O3" value="2945.8303" lower_limit="2516.5662" upper_limit="4579.0958"/>
                    <measurement group_id="O4" value="2601.0945" lower_limit="2241.0882" upper_limit="3226.3642"/>
                    <measurement group_id="O5" value="1934.8479" lower_limit="1442.3779" upper_limit="2951.8173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected over the entire study duration of up to 36 days, with individual subject participation of between 15 to 36 days from the signature of the Informed Consent Form (ICF) until the end of the safety follow-up period.</time_frame>
      <desc>The safety was assessed in the safety population, consisting of all randomized subjects who gave informed consent and had exposure to at least one of the investigational products, including product test, as part of the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>P4M3-1.7% Product Test</title>
          <description>On Admission Day (day -2) all subjects were invited to test the P4M3 product for 10 minutes.</description>
        </group>
        <group group_id="E2">
          <title>Subject's Own E-cigarette</title>
          <description>Subject's own e-cigarette with e-liquid</description>
        </group>
        <group group_id="E3">
          <title>P4M3-1.7%</title>
          <description>P4M3 with e-liquid concentrations of 1.7% nicotine without lactic acid</description>
        </group>
        <group group_id="E4">
          <title>P4M3-1.7%LA</title>
          <description>P4M3 with e-liquid concentrations of 1.7% nicotine with 1.1% lactic acid</description>
        </group>
        <group group_id="E5">
          <title>P4M3-3%LA</title>
          <description>P4M3 with e-liquid concentrations of 3% nicotine with 1.1% lactic acid</description>
        </group>
        <group group_id="E6">
          <title>P4M3-4%LA</title>
          <description>P4M3 with e-liquid concentrations of 4% nicotine with 2% lactic acid</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 20.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Diarrohea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Catheter site inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>We confirm we have the contractual provisions in place which specify that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.
The Intellectual Property rights and research results from the present study belong to the Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Christelle Haziza</name_or_title>
      <organization>Philip Morris Products S.A.</organization>
      <phone>+41 58 242 11 11</phone>
      <email>ClinicalTrials.PMI@pmi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

